# Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions

> **NCT00081731** · PHASE3 · COMPLETED · sponsor: **Baim Institute for Clinical Research** · enrollment: 947 (actual)

## Conditions studied

- Atherosclerosis
- Cardiovascular Diseases
- Hypertension, Renovascular
- Renal Artery Obstruction

## Interventions

- **DRUG:** Atacand/HCT, Caduet
- **PROCEDURE:** GENESISTM Embolic Protection Stent and Angioguard Device (Angioplasty plus stenting)

## Key facts

- **NCT ID:** NCT00081731
- **Lead sponsor:** Baim Institute for Clinical Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 947 (ACTUAL)
- **Last updated:** 2015-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00081731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00081731, "Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00081731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*